Moderna will appeal to the Federal Circuit to assert that its government-contractor immunity limits liability under federal law
The pharmaceutical giant said it would pursue legal and regulatory action following Hims & Hers
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Jubilant successfully challenged Bracco's patent infringement claims in an Inter Parties Review (IPR) proceeding before the U.S. Patent Office
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The dispute stems from an earlier circular by Zuventus allegedly accusing Zorvia of market sabotage
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Subscribe To Our Newsletter & Stay Updated
